symptomatic benign prostatic hyperplasia (BPH) (DBCOND0099889)

Identifiers

Synonyms

Symptomatic Benign Prostatic Hyperplasia / Symptomatic Benign Prostatic Hyperplasia (BPH)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Dutasteride	An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult males by inhibiting 5-alpha reductase.	3-oxo-5-alpha-steroid 4-dehydrogenase 1target 3-oxo-5-alpha-steroid 4-dehydrogenase 2target Sodium-dependent dopamine transportertransporter Synaptic vesicular amine transportertransporter Albumincarrier Alpha-1-acid glycoprotein 1carrier Cytochrome P450 3A5enzyme Polyprenal reductasetarget
Finasteride	An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) and male pattern hair loss in adult males by inhibiting Type II 5-alpha reductase.	3-oxo-5-alpha-steroid 4-dehydrogenase 1target Cytochrome P450 3A4enzyme 3-oxo-5-alpha-steroid 4-dehydrogenase 2target Aldo-keto reductase family 1 member D1target Cytochrome P450 3A5enzyme Cytochrome P450 3A7enzyme Solute carrier family 12 member 5transporter Polyprenal reductasetarget

Clinical Trials

Not Available